Cas No.: 850859-24-4
PRODUCT INFORMATION
Description
LyP-2 (Cys-Asn-Arg-Arg-Thr-Lys-Ala-Gly-Cys) is a tumor-lymphatic-targeting nonapeptide. It exhibits selective homing to lymphatic vessels in several tumor models, such as C8161 melanoma and K14-HPV16-induced carcinomas. It is a research tool used to study lymphatic vessel targeting and to differentiate between tumor and normal tissue lymphatics in preclinical models.
Molecular Weight
1008.18
Purity
> 95%
Formula
C₃₇H₆₉N₁₇O₁₂S₂
Product Type
Targeting Peptide
Sequence
Cys-Asn-Arg-Arg-Thr-Lys-Ala-Gly-Cys
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(RGDyK) Targeting Peptide (CAT#: OLY-1025-YS-52)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- CGGRGD Targeting Peptide (CAT#: OLY-1025-YS-26)
- Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
- Pep2 Targeting Peptide (CAT#: OLY-1025-YS-41)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.